We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
40 hedge funds and large institutions have $274M invested in ESSA Pharma in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
98% more capital invested
Capital invested by funds: $139M → $274M (+$136M)
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
14% more funds holding
Funds holding: 35 → 40 (+5)
1.23% less ownership
Funds ownership: 70.04% → 68.8% (-1.2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
15
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$5.05M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.25M |
| 3 |
SCM
Sio Capital Management
New York
|
-$1.57M |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$1.46M |
| 5 |
Renaissance Technologies
New York
|
-$204K |
